234 related articles for article (PubMed ID: 7482824)
21. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
22. Therapeutic use of monoclonal antibodies in kidney transplantation.
Kreis H; Chkoff N; Vigeral P; Chatenoud L; Lacombe M; Campos H; Pruna A; Goldstein G; Bach JF; Crosnier J
Adv Nephrol Necker Hosp; 1985; 14():389-407. PubMed ID: 3919540
[No Abstract] [Full Text] [Related]
23. Strategies of immunosuppression in cardiac transplantation.
Renlund DG; O'Connell JB; Bristow MR
Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):181-8. PubMed ID: 2127901
[TBL] [Abstract][Full Text] [Related]
24. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
25. Anti-CD3 antibodies.
Chatenoud L; Bach JF
Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
[No Abstract] [Full Text] [Related]
26. Monoclonal antibodies in organ transplantation.
Valdés RH
Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
[No Abstract] [Full Text] [Related]
27. Effect of HLA matching on graft survival in live donor kidney transplantations.
Velidedeoğlu E; Bilgin N; Haberal M
Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
[No Abstract] [Full Text] [Related]
28. OKT3 rescue therapy for 63 refractory rejections in 405 renal allografts.
Uchida K; Namii Y; Tominaga Y; Haba T; Tanaka H; Ichimori T; Uemura O; Morozumi K; Hayashi S; Yokoyama J; Takagi H
Transplant Proc; 1996 Jun; 28(3):1358-9. PubMed ID: 8658693
[No Abstract] [Full Text] [Related]
29. Induction immunosuppression with antithymocyte globulin in renal transplantation using a variable dose according to the absolute number of CD3+ T cells.
Abouna GM; Kumar MS; al-Abdullah IH; Loose J; Sullivan DK; Phillips K; Yost S; Seirka D
Transplant Proc; 1995 Oct; 27(5):2676-8. PubMed ID: 7482872
[No Abstract] [Full Text] [Related]
30. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Watson CJ; Davies HS; Metcalfe SM; Cobbold SP; Rebello PR; Collier DS; Waldmann H; Calne RY
Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
[No Abstract] [Full Text] [Related]
31. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
Alamartine E; Bellakoul R; Berthoux F
Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975
[No Abstract] [Full Text] [Related]
32. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
Rebellato L; Gross U; Carver M; Cunningham P; Riley R; Ross W; Knowles R; Thomas J
Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
[No Abstract] [Full Text] [Related]
33. Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.
Burton RC; Cosimi AB; Colvin RB; Rubin RH; Delmonico FL; Goldstein G; Russell PS
J Clin Immunol; 1982 Jul; 2(3 Suppl):142S-147S. PubMed ID: 6290526
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects.
Chatenoud L
Transplant Proc; 1988 Oct; 20(5 Suppl 6):79-83. PubMed ID: 3140452
[No Abstract] [Full Text] [Related]
35. Immunosuppressive drugs for kidney transplantation.
Halloran PF
N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
[No Abstract] [Full Text] [Related]
36. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
[No Abstract] [Full Text] [Related]
37. Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells.
Yoshimura N; Lee CJ; Shiho O; Kita M; Imanishi J; Oka T
Transplant Proc; 1995 Feb; 27(1):390-1. PubMed ID: 7879033
[No Abstract] [Full Text] [Related]
38. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study.
Opelz G
Transplant Proc; 1997; 29(1-2):73-6. PubMed ID: 9123162
[No Abstract] [Full Text] [Related]
39. Transplantation: new protocols and new worries.
Grinyo JM
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
[No Abstract] [Full Text] [Related]
40. The evolution and future of immunosuppression in renal transplantation.
Goral S; Helderman JH
Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
